Brief: Strata Skin Sciences Highlights New Study Validating Xtrac Laser Plus Topical Drug Combo
Sept 30 (Reuters) - STRATA Skin Sciences Inc SSKN.O: STRATA SKIN SCIENCES RECEIVES CONTINUED VALIDATION FOR ITS PERSONALIZED APPROACH WITH NEW PUBLISHED STUDY HIGHLIGHTING XTRAC® EXCIMER LASER TREATMENT COMBINED WITH A TOPICAL DRUG IN PSORIASIS Source text: ID:nGNX1qQgzq Further company coverage: SSKN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on STRATA Skin Sciences
See all newsBrief: Strata Skin Sciences Appoints Medical Device Commercial Leader Erica Jordan As Chief Executive Officer
Brief: Laseroptek America Filed Counterclaims & Third-Party Claims Against Strata Skin Sciences & Its CEO, In Lawsuit Brought By Strata
Medical tech firm STRATA's Q3 revenue misses estimates as demand in international markets softens
Brief: STRATA Skin Sciences Q3 Revenue USD 6.9 Million
Brief: STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions